Myotonic Dystrophy Global Pipeline
$25
Every company (public and private) in drug development for myotonic dystrophy (DM1/DM2), their drug candidates, mechanisms of action (targets, modalities), stage of development, clinical trial identifiers, initiation dates, clinical statuses and notes (e.g. links, financing data if available, other clinical trial details).
Delivered as a Microsoft Excel document.
Data as of Aug 1 2023.
Delivered as a Microsoft Excel document.
Data as of Aug 1 2023.
$25
Enter a fair price
$
Only $20 for members
Become a member to get a discount and other exclusive benefits.
$25
More from Blackseed Bio’s Shop
Targeted Protein Degradation Global Pipeline
$49
$40 for members
Duchenne Muscular Dystrophy (DMD) Global Market & Pipeline
$99
$89 for members
RAS, SOS1, SHP2 Global Pipeline, Products and Product Sales
$29
$24 for members